Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Additional Paid-in Capital
Accumulated Deficit
Class A common stock
Class B common stock
Total
Beginning balance at Dec. 31, 2019 $ 0 $ (1,000) $ 0 $ 0 $ (1,000)
Beginning balance (in shares) at Dec. 31, 2019     0 0  
Issuance of Class B common stock to Sponsor 24,425 0 $ 0 $ 575 25,000
Issuance of Class B common stock to Sponsor (in shares)     0 5,750,000  
Net loss 0 0 $ 0 $ 0 0
Ending balance at Mar. 31, 2020 24,425 (1,000) $ 0 $ 575 24,000
Ending balance (in shares) at Mar. 31, 2020     0 5,750,000  
Beginning balance at Dec. 31, 2019 0 (1,000) $ 0 $ 0 (1,000)
Beginning balance (in shares) at Dec. 31, 2019     0 0  
Net loss         (82,243)
Ending balance at Sep. 30, 2020 5,082,496 (83,243) $ 182 $ 575 5,000,010
Ending balance (in shares) at Sep. 30, 2020     1,818,719 5,750,000  
Beginning balance at Mar. 31, 2020 24,425 (1,000) $ 0 $ 575 24,000
Beginning balance (in shares) at Mar. 31, 2020     0 5,750,000  
Net loss 0 0 $ 0 $ 0 0
Ending balance at Jun. 30, 2020 24,425 (1,000) $ 0 $ 575 24,000
Ending balance (in shares) at Jun. 30, 2020     0 5,750,000  
Sale of 23,000,000 Units, net of underwriting discounts 216,868,763 0 $ 2,300 $ 0 216,871,063
Sale of 23,000,000 Units, net of underwriting discounts (in shares)     23,000,000 0  
Sale of 650,000 Private Placement Units 6,499,935 0 $ 65 $ 0 6,500,000
Sale of 650,000 Private Placement Units (in shares)     650,000 0  
Common stock subject to possible redemption (218,310,627) 0 $ (2,183) $ 0 (218,312,810)
Common stock subject to possible redemption (in shares)     (21,831,281) 0  
Net loss 0 (82,243) $ 0 $ 0 (82,243)
Ending balance at Sep. 30, 2020 $ 5,082,496 $ (83,243) $ 182 $ 575 $ 5,000,010
Ending balance (in shares) at Sep. 30, 2020     1,818,719 5,750,000